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Sera  from  children  and  adults  with  ulcerative  colitis  contain  antibodies 
against antigen present in phenol-water extracts of sterile human colon (1--4). 
The antigen is heat stable and most likely of polysaccharide nature (5). It seems 
to be tissue specific  and is present in the epithelial ceils  of the colon mucosa 
and probably also in the mucus (4). 
Sterile (i.e.  fetal or newborn) human colon contains only small amounts of 
antigen,  insufficient for detailed studies. Large intestine from adults  cannot 
be used because of its inherent contamination with bacterial antigens, against 
which  antibodies  are present  in most human sera.  Attempts were  therefore 
made  to  use  antigen from germfree  rats  (6).  Such  animals were  considered 
suitable not only because of the absence of an intestinal flora, but also because 
of their strongly hypertrophic cecum and the abundance of water soluble in- 
testinal mucus (7).  It was found that extracts from the intestine of these rats 
contained antigen which reacted with antibodies in the patient's sera in indirect 
hemagglutination and agar precipitation experiments. The antigen was tissue 
specific  and similar to the human colon antigen described earlier. It could be 
obtained in good yields from wall and content of colon and cecum of the rats, 
and did not originate from the diet (6).  This antigen was therefore used for 
further immunochemical studies. 
Human colonic extracts only rarely reacted with sera of healthy control sub- 
jects or those of patients with unrelated diseases,  when tested by the sensitive 
indirect hemagglutination technique. In contrast, most human sera had low or 
moderate  fiters  against  the  rat  extracts,  when tested by the  same method. 
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Knowledge  of  the  specificity  for  ulcerative  colitis  of  the  colon  reactive  anti- 
bodies in the  sera  of these patients  is  essential for an  appreciation  of the pos- 
sible  autoimmtme  etiology of this  disease.  Therefore,  the nature  of this  back- 
ground  reactivity  in  normal  human  sera  had  to  be  investigated.  In  previous 
experiments  with  human  antigen,  extracts  were made  from  colon of newborn 
subjects belonging to blood group O, and it was also observed that the presence 
of anti-A  or  anti-B  isohemagglutinins  did not influence  the  titers  against  the 
tissue  antigen.  However,  human  blood group-like  antigens  are well known  to 
occur in animals (8). It could therefore be assumed that the background activity 
in  normal  sera,  when  tested  with  rat  extracts,  was  due  to  antibodies  to  such 
antigens.  In  this  paper,  the  immunological  relationship  of  the  colon-specific 
antigen from germ_free rats to blood group-specific antigens of the human  ABO 
system will be described. 
Material and Methods 
Sera.--The ulcerative colitis sera were from children and young adults (10 to 25 years old), 
most of them with the disease in a chronic phase. Sera from healthy persons of the same age 
distribution, and from persons with unrelated diseases served as controls. The eel serum was a 
pool from 10 animals. Before use it was freed from lipids by centrifugation at  10,000 g. All 
sera were inactivated at  56°C for 30 minutes.  The human  sera were absorbed  once for 30 
minutes at room temperature with an equal volume of packed and washed sheep erythrocytes. 
The eel serum was absorbed  with human  erythrocytes of blood group  A1B. All sera  were 
stored in small phials at  --20°C until use. 
Antigen.--Antigen  was extracted from germfree rats of the inbred Swedish strain, reared 
according to the technique of Gustafsson  (9,  10). The rats,  which were of the 18th inbred 
generation, were  fed  the  semisynthetic  diet  D7  (10)  and  water  ad libitum. The  diet  was 
sterilized by autoclaving at  121°C for 20 minutes. Cecum, colon (wall and contents), small 
intestine,  stomach,  liver, and  kidney were dissected  out aseptically from animals of both 
sexes.  A pool of each of these organs taken from 10 animals as well as individual samples of 
cecum from 2 additional animals were homogenized separately in a Virtis 45 homogenizer in 
ice cold distilled water and extracted twice for 15 minutes with 90 per cent phenol at 65°C 
according to Westphal et al. (11). Extraction was begun within 3 hours of the animals leaving 
the germfree environment. The water phases,  separated from the phenol by centrifugation, 
were combined, dialyzed for 2 days against running tap water and against three changes of 
distilled water for an additional  2  days. The dialysates were then concentrated  to ~0  the 
original volume by vacuum distillation and were finally precipitated with 6 volumes of 96 per 
cent ethanol (containing traces of sodium acetate) under constant stirring. After standing at 
4°C overnight, the precipitates were collected, dissolved in distilled water, centrifuged if neces- 
sary,  and finally lyophilized. Feces from the germfree rats were extracted in the same way. 
The rats were kept on raised screens and feces were collected from the stainless steel trays on 
the bottom of the cages. This type of collection does not exclude some contamination with 
diet, urine, and hair. Extract of the diet (DT) and of lungs from 20 conventional rats (Sprague 
Dawiey) was also used in some experiments. 
Erythrocytes.--The human  erythrocytes were from healthy blood donors of blood group 
A1, B, A1B, or O (Rh +). The cells were  stored  at  4°C  in  sterile citric acid dextrose (ACD) 
solution and used within  5  weeks.  Sheep  erythrocytes  were  collected  aseptically  in  one 
volume of  sterile Alsever's solution (12) and kept at 4°C until use. ]~L~M~ffARSTROX~,  LAGERCRANTZ,  PERLM~AIW!~,  AND GUSTAFSSON  1077 
ttemagglntinalion.--For  sensitization, 4 ml of saline, contaln;ng 2.0 mg antigen/ml, were 
added to 0.10 ml of packed and washed sheep erythrocytes. Before use, the antigen solution 
was heated to 100°C for 1 hour. After incubation at 37°C for 1 hour, the sensitized erythrocytes 
were washed 3 times and finally diluted to 20 ml with phosphate-buffered saline. Serial twofold 
dilutions of serum were prepared with the buffered saline in perspex trays (2). To each well 
containing 0.1 ml of serum dilution, an equal volume of the erythrocyte suspension was added. 
The trays were kept at room temperature for 18 hours and shaken occasionally. Sensitized 
erythrocytes in saline only, and serum with unsensitized erythrocytes, were used as controls 
in each experiment. Isohemagglutinin titers with human red cells instead of sensitized sheep 
erythrocytes were determined in the same way. 
ttemagglutination Inhibition.--In most experiments, a  dilution series of antigen, used as 
inhibitor, was added to the appropriately diluted sera. The serum dilutions varied from 4 to 
8 hemagglutinating units (HU) (4 to 8 HU =  serum diluted 4 to 8 times less than highest dilu- 
tion causing hemagglutination). The inhibitor was serially diluted in twofold dilution steps 
with antigen concentrations ranging from 8 to 1000/~g/ml. 0.1 ml of each  antigen dilution 
was added to equal volumes of the appropriate serum dilution. After 30 minutes at room 
temperature, 0.1  ml sensitized sheep red blood cells or human erythrocytes were added to 
each mixture. Hemagglutination was read as above after 3 to 4 hours' incubation at room tem- 
perature. The hemagglutinating titers of serum without inhibitor were determined in each 
experiment. Homologous inhibitions with the antigen used for sensitization, or with the ap- 
propriate human red blood cells (of. below), were always performed. In addition to the controls 
mentioned in the previous section, a control containing the inhibitor in its highest concentra- 
tion, 4 to 8 HU of serum, and unsensitized sheep erythrocytes was also set up. 
In some experiments, a  constant amount of inhibitor was added to a  dilution series of 
serum, made up in twofold dilution steps. To 0.1 ml of each serum dilution was added 0.1 ml 
of inhibitor, containing 2.00 mg/ml. After 30 minutes 0.1  mi of the test erythrocytes was 
added and hemagglutination was read as described. 
Absorption.--Packed  and washed human erythrocytes of proper ABO types were mixed 
with equal volumes of undiluted serum and the mixtures were incubated for 30 minutes at 
room temperature. In most cases one absorption was sufficient to remove the corresponding 
isohemagglutinins. In a few cases absorption had to be repeated once or twice. The complete- 
ness of the absorptions was always controlled. In the experiments in which antibody titers 
were compared before and after absorption sheep erythrocytes were added  to the samples 
called "before absorption" in order to compensate for the dilution. 
Fluorescent Antibody StaCning.--The  indirect method was used throughout (13). Ethanol 
fixed and dried cryostate sections (5  #) of freshly dissected proximal colon and distal cecum 
from 3 germfree rats were incubated for 30 minutes with undiluted or diluted serum. After 
washing the sections with buffered saline and drying in a stream of cold air, fluorescein-conju- 
gated rabbit anti-human gamma  globulin was  added.  The human gamma  globulin was a 
commercial Cohn fraction II preparation, further purified bychromatographyand gel filtration. 
Conjugation was performed with fluorescein isothiocyanate on celite (Microbiological Associ- 
ates, Bethesda, Maryland), according to Rinderknecht (14), using the ammonium sulfate- 
precipitated gamma globulin fraction of a hyperimmune rabbit serum. The fluoreseein/protein 
ratio was 3.2 X  10  -3 (15). The sections were incubated with the conjugate at 37°C for 40 
minutes. After washing they were inspected in a fluorescence microscope (Reichert Zetopan, 
Vienna, Austria, equipped with a Osram HB-200 Hg-bumer). For control, tissue sections were 
incubated with the conjugate alone, or with twofold serial dilutions of serum, first absorbed 
either with germfree rat cecum (2.0 mg/ml) or with human erythrocytes (blood group Ax). 
Microphotographs were taken on Kodak tri-X-pan emulsion and an automatic photometer. 1078  ~0LOGICAL  STUDI~S  IN  ULCERATIVE  COLITIS.  II 
RESULTS 
Human sera could be expected to hemagglutinate sheep erythrocytes, sensi- 
tized with cecum extracts from germfree rats, if these extracts contained human 
blood group-like antigens. In a first series of experiments, the effect of absorp- 
tion  with  human  Az  erythrocytes  on  this  hemagglutination  was  examined. 
Text-fig. 1 shows the results of an experiment in which 38 tmselected ulcerative 
colitis sera were tested. As can be seen, this absorption had little effect on the 
antibody titers against the cecum extract. Only in a few sera were the antibody 
titers  reduced  significantly  (~  2  dilution  steps).  All  these  sera  also  had  a 
measurable titer when tested with human A1 erythrocytes (before absorption). 
In order to investigate the significance of this finding, individual  sera were 
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TEX~-I~G. 1. Hemagglutlnation of rat cecum-sensitized sheep erythrocytes with ulcerative 
colitis sera before and after absorption with human A1 erythrocytes. Ordinate, No. of sera. 
Abscissa, reciprocals of titers. Stippled bars, titers before absorption. Empty bars, titers after 
absorption. 
selected for closer examination. These were taken from a sample of 38 ulcerative 
colitis sera and another of 56 unselected controls, comprising healthy persons 
and patients with unrelated  diseases.  Only those  sera were chosen which  (a) 
contained  anti-A  isohemagglutinins,  and  (b)  had  a  hemagglutination  titer 
,~ ~  against sheep red cells sensitized with rat  cecum.  The  percentage  of  sera 
with  anti-A isohemagglutinins was 45 and  52 per cent respectively (difference 
statistically not significant)  and there was no difference in  their  anti-A  titers. 
In the ulcerative colitis group,  16 out of 38 sera fulfilled the criteria given. In 
the control group, this number was only 11 due to the fact that the anticecum 
titers were E  ~  in several sera which contained anti-A isohemagglutinins. The 
results  of A1 erythrocyte  absorptions  on  the hemagglutinating  titers  against 
cecum-sensitized sheep red cells are shown in Table I. It is evident that absorp- 
tion led to titer reductions in both groups. However, in only 6 out of 16 cases 
in  the  ulcerative colitis  group was  this  reduction  ~  2  dilution  steps.  In  the 
control group,  a  corresponding reduction  was found in 9  out of the  11  sera. 
This difference between the  groups was statistically highly significant.  (P  = HAMM'ARSTROM,  LAGERCRANTZ,  PERLMANN,  AND  GUSTA.FSSON  1079 
0.02 when tested by the X  2 test). Moreover, the highest titer reduction in the 
ulcerative colitis group was  3  dilution steps  encountered in only one serum, 
while it was 3 or more dilution steps in 4 of the control sera. 
The possible occurrence of other antigens of the ABO system was studied 
in similar experiments. When 25 ulcerative colitis  sera  containing  anti-B  iso- 
hemagglutinins, were absorbed with human B erythrocytes, no reduction of the 
anticecum fiters ensued. The same was found in the controls (9 out of 40 con- 
taining both anfi-B antibodies and anticecum titer .~ 1/~). The anticecum titers 
of  sera  containing  both  anti-A  and  anti-B  also  remained  unchanged  when 
absorbed with B  erythrocytes after previous absorption with Ax  erythrocytes. 
Absorption with human O erythrocytes of 15 ulcerative colitis sera and  14 con- 
trol sera, which had anticecum titers Y- ~  did not affect hemagglutination of 
TABLE I 
Hemagglutincaion Tilers against Cecum-Senaitized Sheep Erythrocytes in Sera of Patients  with 
Ulcerative Colitis and in Controls before and after Absorption with 
Human AI Erythrocytes 
Type  of  serum 
UC 
Controls 
Absorption* 
+ 
+ 
0 
N 
2 
Reciprocal  of hemagglutination titers 
m 
4  8  16 
--  3 
1  5 
5 
32 
4 
3 
1 
64  128 
4  3 
2  1 
3  -- 
* --, before absorption; +, after absorption. 
sensitized  sheep  erythrocytes. None  of these  sera  agglutinated  human  type 
O cells. 
Further evidence of the presence of blood group A-like antigen in the extract 
of germfree rat cecum was obtained by studying its inhibiting action on the 
hemagglutination of human red blood cells, Table II shows the typical results 
of a  series of hemagglutination inhibition experiments.  As may be seen,  rat 
cecum significantly inhibited the  reaction between  anti-A  isohemagglutinins 
and blood cells of blood group At or A~B, while it did not affect the B/anti-B 
reaction. 
It was of interest to establish whether the rat extract also contained antigen 
similar to the H  substance of the human ABO system. This was studied by 
means of eel serum, known to  contain anti-H agglutinins  (8). Table III gives 
the results of experiments with such  a  serum.  In this experiment, extract of 
feces from the germfree rats was used for sensitization of the sheep erythro- 
cytes. As can be seen, eel serum agglutinated both sheep erythrocytes, sensi- 1080  ~UNOLOGICAL  STUDEES  IN  ULCERATIVE  COLITIS.  II 
tized with rat fecal extract,  and human type 0  erythrocytes.  In both  cases, 
hemagglutination could be inhibited completely with human 0  erythrocytes. 
Table IV shows  that  both  the  rat feces  and cecum  also inhibited eel serum 
when tested with human 0  erythrocytes. 
TABLE II 
Hemagglutination of Human Erythrocytes with Normal Human Serum before  and after Inhibition 
with Cecum Extract of Germfree Rats 
Ai 
AxB 
Test 
erytnrocytes 
Treatment 
OI ~.t  u.ul" 
b 
+ 
+ 
+ 
64 
1 
16 
16 
64 
8 
256 
2 
128 
64 
128 
8 
Serum No.~ 
m 
m 
128 
128 
64 
64 
32 
1 
m 
m 
16 
1 
* --, no inhibitor added. The numbers are reciprocal values of hemagglutlnation  titers; 
q-, inhibitor added. The numbers are  reciprocal values of the lowest serum dilution com- 
pletely inhibited by 2.00 mg/ml cecum extract. 
:~ 1, normal human serum, blood group O; 2, normal human serum, blood group O; 3, 
normal human serum, blood group A; 4, normal human serum, blood group B. 
TABLE III 
Hemagglutination of Feces-Sensitized Sheep Erythrocytes and of Human Erythrocytes with Ed 
Serum* before and after Absorption with Human Group 0  Erythrocytes 
Reciprocal values of hemagglutination titer~ against 
.ADsorption 
0  AI  B  AIB 
Rat feces  erythrocytes  erythrocytes  erythrocytes  erythrocytes 
--  256  512  <8  8  <8 
Once  8  < 8  --  --  -- 
Twice  <8  <8  --  --  -- 
* Eel serum absorbed twice with human A1B erythrocytes before use. 
These experiments provided good evidence that the cecum extract of germ- 
free rats contained human blood group-specific antigens (A and H  but not B), 
as well as a  "colon"-specific antigen, recognized by its reaction with antibodies 
in the ulcerative colitis sera. In order to study the distribution of these antigens 
in  different  rat  organs,  hemagglutination inhibition experiments  were  per- 
formed with various rat  extracts  and a  number of different sera.  The  colon- tLAMMARSTROM,  LAGF.RCRANTZ,  PERLMANN,  AND  GUSTAFSSON  1081 
specific antigen was assayed with the serum of a person of blood group A, tested 
with feces-sensitized sheep erythrocytes (titer  1/32).  The A  antigen was simi- 
larly assayed with serum of a person of blood group O and type A1 erythrocytes 
(titer 1/128), and the B antigen with another group O serum and type B  eryth- 
rocytes  (titer 1/32).  Finally,  the  H  antigen  was assayed with eel serum and 
type O erythrocytes (titer 1/4096). As can be seen from Table IV none of the 
rat specimens used for inhibition contained blood group B-like antigen detect- 
able by this method. In contrast, both feces and extracts from various parts of 
TABLE IV 
Hemagglutination  of Feces-Sensitized Sheep  Erythrocytes  and  of Human  Erythrocytes  with 
Different Human Sera after Inhibition with Different Rat Extracts 
Inhibiting extracts 
Feces 
Cecum 
Small intestine 
Ventricle 
Liver 
Kidney 
Lung 
1 
Rat feces 
-<8 
8 
125 
64 
>1000 
125 
125 
Serum No.* and test antigens 
2  3 
Az erythro-  B erythro- 
cytes  cytes 
_<8  >1000 
-<8  >1000 
64  > 1000 
<8  >1000 
>1000  >1000 
>1000  >1000 
>1000  >1000 
4 
O erythro- 
cytes 
--<8 
--<8 
-<8 
-<8 
500 
250 
500 
The numbers in the table give the minimal quantities of antigen necessary for complete 
inhibition of the hemaggiutinating units (HU) indicated for each serum. 
* l, 4 HU of ulcerative colitis serum, blood group A; 2, 8 HU of ulcerative colitis serum, 
blood group O; 3, 4 HU of ulcerative colitis serum, blood group O; 4, 4 HU of eel serum (not 
absorbed with A1B erythrocytes). 
the gastrointestinal tract contained A  as well as H  antigens. As shown earlier 
(6),  the colon-specific antigen was predominant in cecum and also in feces. It 
may be mentioned  that  the  semisynthetic diet  given  to  the  rats has  earlier 
been shown to be free from the colon-specific antigen  (6). When tested in the 
same way as shown in Table IV, no blood group antigens were found. 
Since  the colon antigen  and the blood group A  antigen were the most im- 
portant  antigens  in  the  hemagglutination  tests,  their  localization  in  the  rat 
large intestine was studied by means of fluorescent antibody staining.  Figs.  1 
and 2 show the staining obtained with the sera of 2 patients, one of blood group 
A, the other of blood group O, (absorbed with human A1 erythrocytes). Fig. 3 
shows the typical results of a  similar experiment with the serum of a  healthy 
person of high  anti-A  titer. As can be seen,  an identical cytoplasmic staining 
of colon mucosa was obtained in all cases. Most conspicuous was the staining 
of goblet  cells in  the  crypts.  Staining  of the mucus,  when present,  was  also 1082  IMMUNOLOGICAL  STUDIES  IN  ULCERATIVE  COLITIS.  II 
seen, whereas the submucosal layers remained unstained. The staining obtained 
with the ulcerative colitis sera could be blocked completely by absorption with 
rat feces. Absorption with A1 erythrocytes entirely removed the staining  ob- 
tained with 5  normal sera containing anti-A isohemagglutinins.  Normal sera 
from blood group A individuals gave no staining. 
DISCUSSION 
The results presented in this paper indicate that organs of the strain of germ- 
free rats used here contain antigen similar to human blood group A  antigen, 
but none slm~lar to blood group B antigen. In this respect, our findings confirm 
those published  recently by Halpern  a  al.  (16).  Using  fluorescent antibody 
staining, these authors found blood group A-like antigen in conventional rat 
colon, but  not in  a  number  of other organs,  including  rat  stomach.  This is 
similar to our results with the hemagglutination inhibition technique, except 
that we also found large amounts of this antigen in rat stomach, small intestine, 
and feces. In their rats, Halpern et o~. also noted that the A antigen was present 
in all individuals animals  tested,  in contrast  to what was  seen in dogs.  Our 
limited experience points in the same direction, since cecum from 3 individual 
rats could be stained with human anti-A isohemagglutinin, and pooled extracts 
from  10  animals  in  hemagglutination  inhibition  experiments  had  the  same 
inhibiting capacity as extracts made from individual animals. 
The blood group A-like antigen was present in phenol-water extracts of the 
rat organs. These extracts also contained a H-like antigen, typical for the hu- 
man ABO system. Both antigens had a  similar,  although not quite identical, 
organ distribution and were present also in the same extracts from individual 
rats. 
The experiments with ulcerative colitis sera demonstrated conclusively that 
the extracts contain a "colon"-specific  antigen, immunologically distinct from 
the  blood group A  and H  antigens  (as  well  as  from the  B  antigen).  While 
absorption  with  human  type A1  erythrocytes reduced  the  hemagglutination 
titer with  rat  antigen slightly,  and  only in  some ulcerative colitis  sera,  this 
reduction  was  strong  in  the  controls.  In  fact,  the majority of  the  elevated 
fiters among the controls was due to the reaction between anti-A isohemagglu- 
tinins  and  the  A  antigen in the  rat  extracts.  Since such hemagglutinins  are 
present in about 50 per cent of the sera in a Swedish population, this explains 
most  of  the  "background"  reactivity noted  earlier  in  the  controls.  Routine 
absorption with type A1 erythrocytes sharpens the difference between ulcera- 
tive colitis patients and controls, when assayed with rat antigen in the hemag- 
glutination test. No  conclusion can as yet be drawn as to the nature  of the 
antibodies which  could not be removed from the control sera by absorption 
with  human  erythrocytes. However,  these  hemagglutination  titers  were low 
and of little significance. Since no such titers were encountered in our previous ILAM'MARSTROM, LAGERCRANTZ, PERLMANN, AND GUSTAFSSON  I08S 
experiments with human antigen, it may perhaps be assumed that the antigen 
involved was different from the colon antigen demonstrable with the ulcerative 
colitis sera. 
Earlier experiments showed,  that the colon antigen of the rat is similar to 
that found in colonic extracts from humans  (6). Since only about 40 per cent 
of the patient's sera, after absorption with A1 erythrocytes, had a significantly 
elevated hemagglutination titer with the rat antigen, while this figure was 90 
per cent in similarly selected sera when tested with the human antigen (1,  2), 
it may be that the rat colon antigen lacks some of the determinants present in 
the human colon antigen.  Further work is required to clarify this point. The 
data  presented  here  also  confirm  and  extend  our  earlier  results  (6)  which 
showed that this antigen is tissue specific in so far as it is most abundant in the 
lower parts of the gastrointestinal tract. The finding of large amounts of antigen 
in the feces of the germfree animals and the results of the fluorescent antibody 
staining both suggest that the antigen is part of the mucus. 
Unpublished chemical data,  indicate that  the colon antigen as well as  the 
A-  and H-like  antigens  are  all  of mucopolysaccharide nature.  However, the 
extracts  were  physicochemically heterogenous.  When  studied  by  means  of 
fractional precipitation and electrophoresis, the blood group antigens and the 
organ-specific colon antigen were found to be enriched in the same fractions. 
Fluorescent antibody staining also suggests that these antigens are related in 
some way, since they are localized to the same sites of the colon tissue. It is 
interesting to speculate whether we are dealing with 2 or 3 types of molecules 
of  different immunological  specificities,  or  with  a  common  carrier molecule 
possessing  both  colon,  A-  and  H-specific determinants.  However,  the  data 
available so far are insufficient to clarify this problem. It must also be empha- 
sized that the situation in man may be different from that in the rat. In regard 
to  the A  antigen,  previous experiments with  human material  give no  clues, 
since  both  immunochemical  experiments  and  fluorescent  antibody  staining 
were performed with specimens from individuals of blood group O (1, 4, 5). On 
the other hand, in regard to the  H  antigen, our earlier experiments suggested 
that extracts of human colon contained both colon antigen and some H  antigen. 
Moreover, the H  antigen and the  immunologically distinct colon antigen also 
had a similar distribution in human colon mucosa (4). 
SUMMARY 
Sera from patients with ulcerative colitis  contain antibodies which hemag- 
glutinate  sheep  red  cells,  sensitized  with  phenol-water  extracts  from  colon, 
cecum, or feces of germfree rats. Minor concentrations of such  antibodies are 
also present in a certain fraction of normal human sera. Hemagglutination and 
hemagglutination  inhibition  experiments with  human  erythrocytes and  with 
the rat extracts showed that the latter contained an antigen similar to human 1084  IMMUNOLOGICAL STUDIES  IN  ULCERATIVE  COLITIS.  II 
blood group A antigen. In contrast, a blood group B-like antigen could not be 
detected in these extracts. However, experiments with eel serum indicated that 
these extracts also contained an antigen similar to the H  antigen of the human 
ABO system. 
Absorption of ulcerative colitis sera with human A1 erythrocytes but not that 
with B  or O erythrocytes'gave, in a few cases, a slight reduction of the hemag- 
glutinating titers against rat cecum-sensitized sheep erythrocytes. In contrast, 
this  treatment  considerably  reduced  such  titers  when  found  in  sera  from 
healthy persons or from patients with unrelated diseases. It could be concluded 
that the rat extracts also contained a "colon" antigen, detected with antibodies, 
present at elevated titers,  in the sera of ulcerative colitis patients,  but not in 
those of the controls. This colon antigen is immunologically distinct from the 
blood group antigens studied. 
Hemagglutination  inhibition  experiments  indicated  that  A,  H  and  colon 
antigen  were widely  distributed  throughout  the  gastrointestinal  tract  of  the 
germfree rats. The colon antigen was found to be enriched in the extracts from 
colon, cecum, and feces. Fluorescent antibody staining provided evidence that 
both the colon antigen and the A  antigen were present in similar sites of the 
colon and cecum mucosa, particularly in goblet cells of the crypts, and in the 
mUCUS. 
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EXPLANATION OF PLATE 65 
FIG. 1. Section of germfree rat colon mucosa stained by the indirect method show- 
ing absorption of antibodies from serum of an ulcerative colitis patient of blood group 
A  onto the goblet cells in the crypts.  X 300. 
FIG. 2. Section of germfree rat cecum mucosa stained by the indirect method show- 
ing absorption of antibodies from serum of an ulcerative colitis patient of blood group 
O  (serum previously absorbed with human A1 erythrocytes) onto the goblet cells in 
the crypts. X  300. 
FIG. 3. Section of germfree rat colon mucosa stained by the indirect method show- 
ing absorption of antibodies from serum of a  healthy person of blood group O  onto 
the goblet cells in the crypts. This serum contains A agglutinins in high titer.  X  300. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  122  PLATE  65 
(Hammarstr6m et al.:  Immunological studies in ulcerative colitis.  II) 